<b>Asterion Ltd</b>???s Agreement With Genzyme Corporation

in

Sheffield, UK, 24th September 2008 Asterion Ltd, the third generation biopharmaceuticals company that is developing novel therapeutic products with superior pharmacological profiles, is pleased to announce today that it has signed a Research and Option Agreement with Genzyme Corp. , one of the world's leading biotechnology companies, to develop a long-acting form of a non-cytokine protein. Under...